NEU neuren pharmaceuticals limited

Possible outcomes?, page-6

  1. 562 Posts.
    lightbulb Created with Sketch.  16
    I wonder if there is another option - the outright sale (licensing?) of Trofinetide.

    I don't see that as viable, for reasons I've stated before i.e. because that would leave a cashed up NEU with 2591 to develop (or as I think of it: Trofinetide 2.0). But this is another option that I don't see listed in your message above Baldwix, and it is a possibility.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Last
$16.66
Change
-0.340(2.00%)
Mkt cap ! $2.147B
Open High Low Volume
$16.99 $17.20 $16.53 524.7K

Buyers (Bids)

Vol. Price($)
1607 $16.64
 

Sellers (Offers)

Price($) Vol.
$16.75 2000
Last trade - 16.25pm 03/07/2026 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.